Literature DB >> 17020777

DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.

S M Costa1, A S Azevedo, M V Paes, F S Sarges, M S Freire, A M B Alves.   

Abstract

We analyzed four DNA vaccines based on DENV-2 NS1: pcENS1, encoding the C-terminal from E protein plus the NS1 region; pcENS1ANC, similar to pcENS1 plus the N-terminal sequence from NS2a (ANC); pcTPANS1, coding the t-PA signal sequence fused to NS1; and pcTPANS1ANC, similar to pcTPANS1 plus the ANC sequence. The NS1 was detected in lysates and culture supernatants from pcTPANS1-, pcENS1- and pcENS1ANC-transfected cells and not in cells with pcTPANS1ANC. Only the pcENS1ANC leads the expression of NS1 in plasma membrane, confirming the importance of ANC sequence for targeting NS1 to cell surface. High levels of antibodies recognizing conformational epitopes of NS1 were induced in mice immunized with pcTPANS1 and pcENS1, while only few pcENS1ANC-inoculated animals presented detectable anti-NS1 IgG. Protection against DENV-2 was verified in pcTPANS1- and pcENS1-immunized mice, although the plasmid pcTPANS1 induced slight higher protective immunity. These plasmids seem to activate distinct patterns of the immune system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020777     DOI: 10.1016/j.virol.2006.08.052

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

1.  Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.

Authors:  Anzhong Li; Miaoge Xue; Zayed Attia; Jingyou Yu; Mijia Lu; Chao Shan; Xueya Liang; Thomas Z Gao; Pei-Yong Shi; Mark E Peeples; Prosper N Boyaka; Shan-Lu Liu; Jianrong Li
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice.

Authors:  Jeremy Fuchs; Haiyan Chu; Peter O'Day; Richard Pyles; Nigel Bourne; Subash C Das; Gregg N Milligan; Alan D T Barrett; Charalambos D Partidos; Jorge E Osorio
Journal:  Vaccine       Date:  2014-09-17       Impact factor: 3.641

3.  Modified mRNA Vaccines Protect against Zika Virus Infection.

Authors:  Justin M Richner; Sunny Himansu; Kimberly A Dowd; Scott L Butler; Vanessa Salazar; Julie M Fox; Justin G Julander; William W Tang; Sujan Shresta; Theodore C Pierson; Giuseppe Ciaramella; Michael S Diamond
Journal:  Cell       Date:  2017-02-17       Impact factor: 41.582

4.  Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.

Authors:  Rúbens Prince Dos Santos Alves; Lennon Ramos Pereira; Denicar Lina Nascimento Fabris; Felipe Scassi Salvador; Robert Andreata Santos; Paolo Marinho de Andrade Zanotto; Camila Malta Romano; Jaime Henrique Amorim; Luís Carlos de Souza Ferreira
Journal:  Clin Vaccine Immunol       Date:  2016-06-06

5.  Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells.

Authors:  Kyung Min Chung; Bruce S Thompson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

Review 6.  Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.

Authors:  Carlo Amorin Daep; Jorge L Muñoz-Jordán; Eliseo Alberto Eugenin
Journal:  J Neurovirol       Date:  2014-10-07       Impact factor: 2.643

7.  Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines.

Authors:  Simone M Costa; Anna Paula Yorio; Antônio J S Gonçalves; Mariana M Vidale; Emmerson C B Costa; Ronaldo Mohana-Borges; Marcia A Motta; Marcos S Freire; Ada M B Alves
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

8.  Expression, purification, and evaluation of diagnostic potential and immunogenicity of a recombinant NS3 protein from all serotypes of dengue virus.

Authors:  Laura Mónica Alvarez-Rodríguez; Angel Ramos-Ligonio; José Luis Rosales-Encina; María Teresa Martínez-Cázares; Aurora Parissi-Crivelli; Aracely López-Monteon
Journal:  J Trop Med       Date:  2012-12-03

Review 9.  Current progress in dengue vaccines.

Authors:  Shu-Wen Wan; Chiou-Feng Lin; Shuying Wang; Yu-Hung Chen; Trai-Ming Yeh; Hsiao-Sheng Liu; Robert Anderson; Yee-Shin Lin
Journal:  J Biomed Sci       Date:  2013-06-13       Impact factor: 8.410

10.  The synergistic effect of combined immunization with a DNA vaccine and chimeric yellow fever/dengue virus leads to strong protection against dengue.

Authors:  Adriana S Azevedo; Antônio J S Gonçalves; Marcia Archer; Marcos S Freire; Ricardo Galler; Ada M B Alves
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.